2,4,5,6,7-Pentabromo-1H-benzoimidazole
CAS: 16865-25-1
Ref. 3D-RAA86525
| 1g | Discontinued | ||
| 5g | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
Name:
2,4,5,6,7-Pentabromo-1H-benzoimidazole
Synonyms:
- 2,4,5,6,7-Pentabromo-1H-benzoimidazole
- 2,4,5,6,7-pentabromo-1H-benzimidazole
- 16865-25-1
Description:
2,4,5,6,7-Pentabromo-1H-benzoimidazole is a modulating molecule that has been shown to inhibit leukemias by binding to tyrosine kinases. The hydroxyl group on the 2 position of the benzene ring binds to the ATP site of the enzyme and blocks the phosphorylation of tyrosine residues on the protein substrate. This inhibition is due to an increase in the rate of protein turnover, which leads to a decrease in protein synthesis and cell division. The 2,4,5,6,7-pentabromo-1H-benzoimidazole inhibits cancer cell growth by inhibiting protein synthesis and inducing apoptosis.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
512.62 g/mol
Formula:
C7HBr5N2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
